VC  New Science Ventures

https://www.newscienceventures.com/





     Office Locations:

Michelin House, 81 Fulham Road
London, SW3 6RD
UK
Phone: 020-3981-9092
Fax: 020-3981-9100

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Information Technology
  • Manufacturing & Industrial

  •  

    Description:

    New Science Ventures, LLC (NSV) is a New York-based venture capital firm which invests in companies using novel scientific approaches in the Life Sciences sector (biotech, pharma and medical devices) and the Information Technology sector (semiconductors, photonics and advanced materials). NSV was founded in 2004 by Somu Subramaniam, Managing Partner, and Tom Lavin, Partner, and has invested approximately $600 million in early-, mid- and late-stage companies located in the US, Europe, India and China. The firm looks for companies that address large, global markets (> $1 billion).


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Andrew Abrams Partner
    Brenda Marex Partner and Chief Financial Officer
    Jean-Pierre Bizet Partner and Senior Advisor
    Raju Mohan Partner and Senior Advisor
    Somu Subramaniam Managing Partner

     

    Portfolio companies include:


      Akarna Therapeutics
        web link


      Alexar Therapeutics
        web link


      Caringo
        web link


      Dezima


      Dust Identity
        web link


      EXTEN Technologies


      Ferric Semiconductor


      Glydways


      GTxcel


      iCAD


      INTERlink AI


      Juventas Therapeutics
        web link


      Kateeva


      Long Wall


      Mangstor
        web link


      NorthSea Therapeutics


      Ovizio Imaging Systems


      Paradigm Diagnostics
        web link


      Phase Four
        web link


      PlanetiQ
        web link


      Resolve Therapeutics
        web link


      Solicore
        web link


      Svelte Medical Systems


      Vaultive


      VORAGO Technologies
        web link


      VUV Analytics
        web link


     

    Recent News: